highlight monocytic expression of the RAC1-PAK1 axis, the final common pathway of multiple immune signaling cascades that may predict patient response to anti-TNFα agents in both IBD and rheumatoid arthritis (RA) using cell-centered individual-level disruption networks, a computational method to examine high-throughput blood omics. This evidence concerns the gene RAC1 and inflammatory bowel disease.